HK Stock Market Move | DAMAI ENT(01060) rose more than 6% after profit, expecting mid-term net profit to increase by no less than RMB 500 million, with excellent performance in Alibaba's fishery business.
Da Mai Entertainment (01060) rose more than 6% after announcing profits, as of press time, it is up by 5.32%, trading at 0.99 Hong Kong dollars, with a turnover of 50.5363 million Hong Kong dollars.
DAMAI ENT (01060) rose more than 6% after the profit, and as of the time of publication, it rose by 5.32% to 0.99 Hong Kong dollars, with a turnover of 50.5363 million Hong Kong dollars.
On the news front, on November 6th, DAMAI ENT announced that it expects the Group's net profit attributable to shareholders for the six months ending September 30, 2025 to be no less than 500 million yuan, while the net profit attributable to shareholders for the six months ending September 30, 2024 was approximately 337 million yuan. The increase in the above net profit is mainly attributed to the following factors: the Group's performance in the Alibaba Fisheries business is excellent, with strong growth in both revenue and profit year-on-year; and the Group's asset structure is becoming more robust, with further reduction in investment portfolio risk exposure and narrowing of investment losses year-on-year.
Furthermore, the Group's cash reserves are abundant, and the Group will be positioned to invest in the diversified entertainment industry field. In the medium to long term, the Group expects its main business to achieve sustained and healthy growth.
Related Articles

SHINEWAY PHARM (02877) had a revenue of 2.415 billion RMB in the first three quarters, a decrease of 16.3% year-on-year.

FIRST PACIFIC (00142) has completed the proposed demerger of MAYNILAD WATER SERVICES, INC. and will independently list on the Philippine Stock Exchange.

BOAN BIOTECH (06955): Two types of Dexu Monoclonal Antibody Injections have been accepted for market approval in the United Kingdom.
SHINEWAY PHARM (02877) had a revenue of 2.415 billion RMB in the first three quarters, a decrease of 16.3% year-on-year.

FIRST PACIFIC (00142) has completed the proposed demerger of MAYNILAD WATER SERVICES, INC. and will independently list on the Philippine Stock Exchange.

BOAN BIOTECH (06955): Two types of Dexu Monoclonal Antibody Injections have been accepted for market approval in the United Kingdom.

RECOMMEND

SERES Faces Market Test in Hong Kong: Shares Open Below Issue Price Despite HK$220 Billion Market Valuation
06/11/2025

Copper Prices Surge While Former “Copper King” Who Outpaced Huawei and Tencent Falls into Decline
06/11/2025

National Energy Administration Reports New-Type Energy Storage Capacity Exceeds 100 Million Kilowatts by End‑September
06/11/2025


